Oral zinc sulfate in the treatment of rosacea: A double-blind, placebo-controlled study

International Journal of Dermatology

Volumn 45, Issue 7, 2006, Pages 857-861

  Sharquie, Khalifa E ^a   Najim, Rafid A ^a   Al Salman, Hala N ^a  

^a UNIVERSITY OF BAGHDAD   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; ZINC SULFATE;

ADULT; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; IRAQ; MALE; OUTPATIENT CARE; RANDOMIZED CONTROLLED TRIAL; ROSACEA; SCORING SYSTEM; STOMACH DISEASE; TEACHING HOSPITAL;

ADMINISTRATION, ORAL; ADULT; ASTRINGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; ROSACEA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; ZINC SULFATE;

EID: 33745595335     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.02944.x     Document Type: Article

References (17)

1. Plewig G, Jansen T. Rosacea. In: Fitzpatrick TB, Freedberg IM, Fisen AZ, eds. Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999: 784-794.
2. Greaves MW. Flushing and flushing syndromes, rosacea and perioral dermatitis. In: Champion RH, Burton JL, Burns DA, et al. eds. Textbook of Dermatology, 6th edn. Vol. 3. Oxford: Blackwell Scientific Publications, 1998: 2099-2112.
3. Abell E. Inflammatory diseases of epidermal appendages and of cartilage. In: Lever's Histopathology of the Skin, 8th edn. New York: McGraw-Hill, 1997: 404-406.
4. Bamford JT, Elliot BA, Haller IV. Tacrolimus effect on rosacea. J Am Acad Dermatol 2004: 107-108.
5. Sharquie KA, Najim RA, Farjou IB, et al. Oral zinc sulphate in treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol 2001; 26: 21-26.
6. Al-Gurairi F, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: Randomized placebo controlled clinical trial. Br J Dermatol 2002; 146: 423-431.
7. Berne B, Venge P, Ohman S. Perifolliculitis capitis abscendens et suffodiens (Hoffman): Complete healing associated with oral zinc sulphate. Arch Dermatol 1985; 121: 1028-1030.
8. Dreno B, Daniel F, Allaert FA, et al. Acne: Evolution of clinical practice and therapeutic management of acne between 1996 and 2000. Eur J Dermatol 2003; 13: 166-170.
9. Hirsch RJ, Weinberg JM. Rosacea 2000. Cutis 2000; 66: 125-128.
10. Johan YH. A therapeutic trial in rosacea of metronidazole and azithromycin. MSc Thesis. Iraq: College of Medicine, University of Baghdad, 2004.
11. Oztas MO, Balk M, Ogus E, et al. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol 2003; 28: 188-192.
12. Rostan EF, DeBuys HV, Madey DL, et al. Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol 2002; 41: 606-608.
13. Fridlander B, Chejanovsky N, Becher Y. Selective inhibition of herpes simplex virus type I DNA-polymerase by zinc ion. Virology 1978; 81: 551-554.
14. Al-Mulla Hummadi YM, Najim RA, Al-Bashir NM. The mechanism behind the antileishmanial effect of zinc sulphate. I An in vitro study. Ann Trop Med Parasitol 2005; 99: 27-36.
15. Roihu T, Kariniemi AL. Domedex mites in acne rosacea. J Cutan Pathol 1998; 25: 550-552.
16. Mayer-Kanhauser S, Kranke B, Kaddu S, et al. Resolution of granulomtous rosacea after eradication of Helicobactor pylori with clarithromycin, metronidazole and pantoprozole. Eur J Gastoentrol Hepatol 2001; 13: 1379-1383.
17. Al-Baghdadi B. A possible useful effect of zinc carbonate in peptic ulceration. MSc Thesis. Iraq: College of Medicine, University of Baghdad, 1999.